South Korea
· Delayed Price · Currency is KRW BCWORLD PHARM. Statistics
Total Valuation
BCWORLD PHARM. has a market cap or net worth of KRW 42.19 billion. The enterprise value is 121.48 billion.
| Market Cap | 42.19B |
| Enterprise Value | 121.48B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
BCWORLD PHARM. has 9.28 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 9.28M |
| Shares Outstanding | 9.28M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 5.27% |
| Owned by Institutions (%) | n/a |
| Float | 8.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.57 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | 10.15 |
| P/OCF Ratio | 6.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.45, with an EV/FCF ratio of 29.24.
| EV / Earnings | -24.61 |
| EV / Sales | 1.63 |
| EV / EBITDA | 13.45 |
| EV / EBIT | 94.37 |
| EV / FCF | 29.24 |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 1.18.
| Current Ratio | 0.47 |
| Quick Ratio | 0.26 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 9.62 |
| Debt / FCF | 20.92 |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is -4.72% and return on invested capital (ROIC) is 0.49%.
| Return on Equity (ROE) | -4.72% |
| Return on Assets (ROA) | 0.45% |
| Return on Invested Capital (ROIC) | 0.49% |
| Return on Capital Employed (ROCE) | 1.59% |
| Revenue Per Employee | 261.74M |
| Profits Per Employee | -17.38M |
| Employee Count | 284 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.42 |
Taxes
In the past 12 months, BCWORLD PHARM. has paid 607.20 million in taxes.
| Income Tax | 607.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.60% in the last 52 weeks. The beta is 0.93, so BCWORLD PHARM.'s price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -12.60% |
| 50-Day Moving Average | 4,685.20 |
| 200-Day Moving Average | 4,561.51 |
| Relative Strength Index (RSI) | 32.60 |
| Average Volume (20 Days) | 8,273 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BCWORLD PHARM. had revenue of KRW 74.33 billion and -4.94 billion in losses. Loss per share was -531.30.
| Revenue | 74.33B |
| Gross Profit | 27.85B |
| Operating Income | 1.29B |
| Pretax Income | -2.96B |
| Net Income | -4.94B |
| EBITDA | 9.03B |
| EBIT | 1.29B |
| Loss Per Share | -531.30 |
Balance Sheet
The company has 7.14 billion in cash and 86.92 billion in debt, giving a net cash position of -79.77 billion or -8,594.17 per share.
| Cash & Cash Equivalents | 7.14B |
| Total Debt | 86.92B |
| Net Cash | -79.77B |
| Net Cash Per Share | -8,594.17 |
| Equity (Book Value) | 73.59B |
| Book Value Per Share | 8,777.66 |
| Working Capital | -49.28B |
Cash Flow
In the last 12 months, operating cash flow was 6.22 billion and capital expenditures -2.06 billion, giving a free cash flow of 4.16 billion.
| Operating Cash Flow | 6.22B |
| Capital Expenditures | -2.06B |
| Free Cash Flow | 4.16B |
| FCF Per Share | 447.66 |
Margins
Gross margin is 37.47%, with operating and profit margins of 1.73% and -6.64%.
| Gross Margin | 37.47% |
| Operating Margin | 1.73% |
| Pretax Margin | -3.99% |
| Profit Margin | -6.64% |
| EBITDA Margin | 12.15% |
| EBIT Margin | 1.73% |
| FCF Margin | 5.59% |
Dividends & Yields
This stock pays an annual dividend of 90.91, which amounts to a dividend yield of 1.98%.
| Dividend Per Share | 90.91 |
| Dividend Yield | 1.98% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | 1.87% |
| Earnings Yield | -11.70% |
| FCF Yield | 9.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 27, 2024. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 27, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
BCWORLD PHARM. has an Altman Z-Score of 0.69 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.69 |
| Piotroski F-Score | 5 |